Investigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy.
AuthorsPearson, M A
O'Farrell, A M
Dexter, T Michael
Whetton, Anthony D
Owen-Lynch, P J
Heyworth, Clare M
AffiliationCancer Research Campaign Laboratories, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractStem Cell Factor (SCF), the ligand for the c-kit proto-oncogene, has been shown to synergistically interact with other cytokines, enhancing the responsiveness of haemopoietic precursors. In this study we have examined the effects of SCF, in combination with interleukin-3 (IL-3), on FDCP-Mix A4 cells, a murine, multipotent, haemopoietic progenitor cell line. Low concentration of IL-3 act to enhance cell survival but do not stimulate proliferation in A4 cells. Similarly, SCF when added alone, acts as a good survival stimulus, but is a poor proliferative stimulus. However, in combination with low concentrations of IL-3, SCF stimulates a synergistic enhancement of proliferation leading to a large increase in cell number after seven days. The synergy observed was not due to SCF stimulated alterations in the mRNA, protein levels or affinity of the IL-3 receptors. Therefore, interactions between cytokines at the level of cytoplasmic signalling pathways were investigated. IL-3 stimulated the rapid and transient tyrosine phosphorylation of several proteins (including those of molecular weights 130, 110, 100, 95, 80, 65, 50 and 45 kDa). Some of these proteins were identified as the Src Homology Collagen (SHC) protein, Janus kinase (JAK-2) and the Mitogen Activated Protein Kinase isoforms ERK 1 and ERK 2. IL-3 also stimulated a transient increase in the activity of both ERK 1 and 2. SCF stimulated a rapid and transient increase in the tyrosine phosphorylation of ERK 1 and ERK 2 although, coaddition of SCF with IL-3, caused no gross differences in the phosphorylation of SHC, JAK-2 or ERKs compared to those observed with IL-3 alone. Coaddition of SCF and low concentration of IL-3 stimulated a reproducible synergistic increase in the activity of ERK 2, whereas only an additive increase in the activity of ERK 1 was observed. These results suggest that ERK 2 activation represents a point at which the two pathways, stimulated by IL-3 and SCF, interact synergistically.
CitationInvestigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy. 1998, 15 (4):293-306 Growth Factors
- Intracellular signaling mechanisms leading to synergistic effects of endothelin-1 and stem cell factor on proliferation of cultured human melanocytes. Cross-talk via trans-activation of the tyrosine kinase c-kit receptor.
- Authors: Imokawa G, Kobayasi T, Miyagishi M
- Issue date: 2000 Oct 27
- IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
- Authors: Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, Anderson KC
- Issue date: 1997 Sep 1
- Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
- Authors: Walker F, Kato A, Gonez LJ, Hibbs ML, Pouliot N, Levitzki A, Burgess AW
- Issue date: 1998 Dec
- Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
- Authors: Liang L, Zhou T, Jiang J, Pierce JH, Gustafson TA, Frank SJ
- Issue date: 1999 May
- Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
- Authors: Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP
- Issue date: 2002 Mar 28